Z-0841-2021 Class II Ongoing

Recalled by Fresenius Medical Care Holdings, Inc. — Waltham, MA

FDA device recall Z-0841-2021 was initiated by Fresenius Medical Care Holdings, Inc. on Nov 23, 2020 and is designated Class II. Reason for recall: The deviation in conductivity for sodium level exceeds 0.6mS/cm from the theoretical conductivity (TCD) or approximately 6mEq/L of sodium from prescriptions that was previously communicated. Calcium… The recall status is ongoing. Affected quantity: 2 drums.

Recall details

Product Type
Devices
Report Date
Jan 20, 2021
Initiation Date
Nov 23, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2 drums

Product description

Citrasate Liquid Acid concentrate drums, Product Code 13-2251 -CA - Product Usage: used in conjunction with Fresenius Renal Technologies Sodium Bicarbonate Concentrate in a compatible 45X dilution three-stream artificial kidney (hemodialysis) machine.

Reason for recall

The deviation in conductivity for sodium level exceeds 0.6mS/cm from the theoretical conductivity (TCD) or approximately 6mEq/L of sodium from prescriptions that was previously communicated. Calcium concentration is below manufacturing specification.

Distribution pattern

US Nationwide distribution.

Code information

Lot Numbers: 20LXAC033 20NXAC004 Additional Affected lots as of 3/17/21: 20LXAC031 20NXAC004 20LXAC033 20NXAC003 20LXAC032

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0841-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0841-2021. Report a data issue: hello@regdatalab.com.